Tara Bancroft
Stock Analyst at TD Cowen
(2.69)
# 2,029
Out of 4,711 analysts
8
Total ratings
50%
Success rate
31.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TGTX TG Therapeutics | Initiates: Buy | $50 | $32.20 | +55.28% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $41.49 | +56.66% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $8.50 | +29.41% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $3.49 | +186.53% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $41.85 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $14.68 | - | 1 | Aug 31, 2022 |
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $32.20
Upside: +55.28%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $41.49
Upside: +56.66%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $8.50
Upside: +29.41%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $3.49
Upside: +186.53%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $41.85
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $14.68
Upside: -